Washington, DC 20549
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 24, 2023 (April 20, 2023)
Humana Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-5975 61-0647538
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
500 West Main Street, Louisville, Kentucky 40202
(Address of principal executive offices, including zip code)

(502) 580-1000
(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock HUM New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Item 5.07    Submission of Matters to a Vote of Security Holders.

The regular annual meeting of the stockholders of Humana Inc. was held in Louisville, Kentucky, on April 20, 2023, for the purpose of voting on the proposals described below. Proxies for the meeting were solicited pursuant to Section 14(a) of the Securities Exchange Act of 1934 and there was no solicitation in opposition to management’s nominees for directors. All nominees for director listed below were elected. The term of office for each director will be until the next annual meeting or until their successors shall be elected and qualified.

Proposal #1: The final results of the election of directors were as follows:
Name For Against Abstained Broker Non-Votes
Raquel C. Bono, M.D. 108,733,911 577,843 85,837 4,607,399
Bruce D. Broussard 108,862,747 365,918 168,926 4,607,399
Frank A. D’Amelio 96,575,811 12,678,182 143,598 4,607,399
David T. Feinberg, M.D. 108,866,429 416,197 114,965 4,607,399
Wayne A. I. Frederick, M.D. 105,337,854 3,941,753 117,984 4,607,399
John W. Garratt 108,588,372 693,980 115,239 4,607,399
Kurt J. Hilzinger 106,220,441 3,090,126 87,024 4,607,399
Karen W. Katz 105,499,171 3,732,562 165,858 4,607,399
Marcy S. Klevorn 109,002,195 291,284 104,112 4,607,399
William J. McDonald 106,266,276 3,041,634 89,681 4,607,399
Jorge S. Mesquita 106,453,512 2,835,195 108,884 4,607,399
Brad D. Smith 108,903,367 393,757 100,467 4,607,399

In addition, the stockholders voted on the following proposals and cast their votes as described below:

Proposal #2 For Against Abstained Broker Non-Votes
Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 108,681,100 5,250,040 73,850 N/A

Proposal #3 For Against Abstained Broker Non-Votes
Board proposal regarding advisory approval of the
Company’s executive compensation
99,607,320 9,492,897 297,374 4,607,399

Proposal #4 Every Year Every Two Years Every Three Years Abstain
Board proposal regarding advisory vote with respect to the frequency of future stockholder votes on executive compensation 107,067,594 108,274 2,119,797 101,926

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
/s/ John-Paul W. Felter
John-Paul W. Felter
Senior Vice President, Chief Accounting Officer and Controller
(Principal Accounting Officer)
Dated: April 24, 2023

Humana (NYSE:HUM)
Historical Stock Chart
Von Aug 2023 bis Sep 2023 Click Here for more Humana Charts.
Humana (NYSE:HUM)
Historical Stock Chart
Von Sep 2022 bis Sep 2023 Click Here for more Humana Charts.